Sarcomas Withdrawn Phase 1 Trials for Pazopanib (DB06589)

Also known as: Sarcoma / Malignant neoplasm of soft tissues / Malignant soft tissue neoplasm / Malignant soft tissue neoplasm NOS / Soft tissue cancer / Sarcoma NOS / Soft tissue sarcoma

IndicationStatusPhase
DBCOND0041813 (Sarcomas)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01130623A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid TumorsTreatment